Skip to content
CompanySight
Company No. 15443042 · Incorporated 25 Jan 2024

Wellcome Genome Campus Limited

Registered name: WELLCOME GENOME CAMPUS LIMITED

Part of Mills & Reeve LLP group

Wellcome Genome Campus Limited made £6.6m revenue and a £2.6m loss in the year to 30 Sep 2025.

Wellcome Genome Campus Limited’s revenue was £6.6m in the year to 30 Sep 2025, with a loss of £2.6m and 28 employees. The company is classified under “management of real estate on a fee or contract basis” and is based in Hinxton.

Full P&L filedSection L · Real estate activitiesSIC 68320Management of real estate on a fee or contract basis
Status
Active
Location
Hinxton, East of England
Age
2 yrs · since 2024
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Sep 2025

Key figures

Revenue
£6.6m
Growth —
Profit
−£2.6m
Growth —
Profit margin
−39.9%
Gross 60.8%
Employees
28
Change —
Profit / employee
−£93.8k
Revenue/employee £235k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

1 filed year

Financial history

Multi-year financials, oldest to newest
Year to30 Sep 2025
DisclosureFull P&L
Profit & loss
Revenue (turnover)£6.6m
Cost of sales−£2.6m
Gross profit£4m
Operating profit−£2.6m
Profit before tax−£2.6m
Profit after tax−£2.6m
Profit (best available)−£2.6m
Employees (average)28
Ratios
Profit margin−39.9%
Gross margin60.8%
Revenue per employee£235k
Profit per employee−£93.8k
Balance sheet — indirect signals, not revenue
Net assets—
SourceAccounts · bulk data Feb 2026
Derived from the latest filing

How the business works

Profit margin
−39.9%
Profit ÷ revenue.
Gross margin
60.8%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£235k
Revenue ÷ average employees.
Profit per employee
−£93.8k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now —
Cash at bank
—
Now —
Headcount
—
Now 28
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Mills & Reeve LLPultimate parent75–100%
  2. Mills & Reeve Trust Corporation Limited75–100%
  3. Gower Place Investments Limited75–100%
  4. Wellcome Genome Campus Holdings Limited75–100%
  5. Wellcome Genome Campus Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from accounts for the year to 30 Sep 2025 (profit −£2.6m), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Updated from Companies House on 14 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.